STOCK TITAN

Docusign SEC Filings

DOCU NASDAQ

Welcome to our dedicated page for Docusign SEC filings (Ticker: DOCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Docusign, Inc. filings document the public-company record for a cloud software business built around Intelligent Agreement Management, e-signature and contract lifecycle management. Its 8-K reports cover operating results, financial-condition updates, share repurchase authorization disclosures and material governance events, including appointments to the board of directors and related independence determinations.

Proxy materials provide formal disclosure on board structure, director matters, executive compensation, equity awards and stockholder meeting governance. Together, the filings describe Docusign’s reporting obligations, capital-return actions, governance framework and compensation practices alongside the operating performance of its agreement-management software business.

Rhea-AI Summary

DocuSign, Inc. Chief Financial Officer Blake Jeffrey Grayson reported selling 6,500 shares of the company’s common stock on January 9, 2026 at a price of $70 per share. The filing states that the transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person, indicating it was pre-arranged rather than a discretionary trade. After this sale, Grayson directly held 111,713 shares of DocuSign common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.56%
Tags
insider
-
Rhea-AI Summary

DocuSign, Inc. President and CEO Allan C. Thygesen reported planned sales of company common stock. On January 9, 2026, he completed three open-market sales under a Rule 10b5-1 trading plan. The reported transactions were sales of 16,151 shares at $69.35, 9,799 shares at $69.98, and 300 shares at $70.83 per share. Footnotes note that the shares in each trade were sold within stated price ranges and that full price breakdowns are available on request. Following these sales, Thygesen directly beneficially owned 142,261 shares of DocuSign common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.56%
Tags
insider
-
Rhea-AI Summary

A shareholder of DocuSign has filed a notice of proposed sale under Rule 144 to sell 26,250 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 01/09/2026. The filing lists an aggregate market value of $1,832,250.00 for these shares, compared with 200,272,740 shares outstanding of the same class.

The shares to be sold were acquired as restricted stock units from the issuer on 10/10/2024, in a non-cash transaction noted as “N/A” for the nature of payment. The filer represents that they are not aware of undisclosed material adverse information about DocuSign’s current or prospective operations, as required for a Rule 144 sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

DocuSign common stockholder Blake J. Grayson has filed a Form 144 notice to sell 6,500 shares of DocuSign common stock, with an aggregate market value of $455,000. The planned sale is to be executed through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of 01/09/2026. The shares to be sold are common stock originally acquired as restricted stock from the issuer on 06/10/2024, in the same 6,500-share amount.

The notice also reports that during the past three months, Blake J. Grayson sold an additional 9,515 DocuSign common shares on 12/17/2025 for gross proceeds of $650,214.18. The filing states that DocuSign had 200,272,740 common shares outstanding. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about DocuSign’s current or prospective operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

DocuSign, Inc. Chief Revenue Officer Paula Hansen reported multiple open-market sales of company common stock. On January 2, 2026, she sold a total of 6,000 shares of DocuSign common stock in four separate transactions, at reported prices of $65.43, $66.94, $67.78, and $68.62 per share.

The filing states that these sales were made under a pre-arranged Rule 10b5-1 trading plan adopted by Hansen, which is designed to allow insiders to sell shares according to a preset schedule. Following the reported sales, Hansen directly beneficially owned 68,970 shares of DocuSign common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Docusign, Inc. reported that its Chief Legal Officer, James P. Shaughnessy, sold common stock in multiple transactions on 01/02/2026. He sold a total of 12,000 shares of Docusign common stock in four separate sales, at prices generally between $64.97 and $68.68, as reflected by the detailed price ranges in the footnotes. These sales were executed pursuant to a Rule 10b5-1 trading plan previously adopted by Shaughnessy. Following the reported transactions, he beneficially owned 54,550 shares of Docusign common stock directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

DocuSign, Inc. director reported an insider transaction involving company common stock. On 12/10/2025, the reporting person made a transaction coded "G" (a gift) of 15,000 shares of common stock at a stated price of $0, held indirectly through a trust.

After this transaction, the reporting person beneficially owned 120,253 shares of DocuSign common stock indirectly through a trust, in addition to 7,512 shares held directly, 65,558 shares held indirectly by children's trusts, 6,458 shares held indirectly by a spouse, and 3 shares held indirectly through a family partnership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

DocuSign, Inc. Chief Financial Officer, identified as an officer of the company, reported multiple equity transactions in December 2025. On 12/15/2025, the CFO acquired 37,453 shares of common stock at $0 through the vesting and settlement of restricted stock units (RSUs) and performance stock units (PSUs), and 15,385 shares were withheld to cover tax obligations. Following these transactions, the CFO directly held 127,728 shares of common stock.

On 12/17/2025, the CFO sold 3,525 shares at an average price within a range of $67.31 to $68.29, and 5,990 shares at prices ranging from $68.33 to $69.05, under a pre-established Rule 10b5-1 trading plan. The filing also details ongoing RSU and PSU awards that vest over several years or based on DocuSign’s FY25 subscription revenue and free cash flow performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

DocuSign's chief legal officer reported multiple stock-based compensation events on December 15, 2025. Several batches of restricted stock units (RSUs) and performance stock units (PSUs) converted into common stock at an exercise price of $0, adding 20,968 shares of common stock.

To cover taxes on these vestings, 9,860 shares were withheld by the company, reducing the net increase in directly held stock. After the reported transactions, the officer directly owned 66,550 shares of DocuSign common stock. The filing also details remaining RSU and PSU awards that continue to vest over time based on service and performance conditions tied to subscription revenue and free cash flow for specified performance periods.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

DocuSign, Inc.’s Chief Revenue Officer reported equity award activity involving company stock. On 12/15/2025, the executive acquired 32,515 shares of DocuSign common stock at $0 following the vesting and settlement of restricted stock units (RSUs) and performance stock units (PSUs). To cover tax obligations triggered by this vesting, 16,513 shares were withheld by the company, also at $0 per share. After these transactions, the officer directly beneficially owned 74,970 shares of common stock. The filing also shows continuing holdings of RSUs and PSUs that may convert into additional shares over time, subject to time-based vesting, performance targets tied to subscription revenue and free cash flow for the FY25 performance period, and continued service conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Docusign (DOCU) SEC filings are available on StockTitan?

StockTitan tracks 138 SEC filings for Docusign (DOCU), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Docusign (DOCU)?

The most recent SEC filing for Docusign (DOCU) was filed on January 13, 2026.